SABBY 13G GALE 6.12.16

Company

SELLAS Life Sciences Group, Inc.

Filed

July 12, 2016

Accession Number

0001535610-16-000157

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →